Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Email today from Matt P.

<< Previous

Bullboard Posts

Next >>

Comment by BlueFrankyon Dec 12, 2024 11:23am

141 Views

Post# 36358973

RE:RE:Email today from Matt P.

Perhaps the back and forth with the Pre-BTD.. (new format they wish us to report in) will afford us the luxury of being on the same playing field.. and truly compare apples with apples!

- that we aren't already blowing through AA based on what is already known comparatively.. that we are a viable effective and safe solution for 75% of patients that CG oncology and others can't touch should be screamed from the hilltops.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal